已收盤 11-20 16:00:00 美东时间
-2.200
-7.67%
11月18日,Alamar Biosciences(ALMR)收涨0.29%,报30.64美元,成交额1414.58万美元,市值21.29亿美元。 行情数据 ...
11-18 06:23
Alamar Biosciences' NULISA precision proteomic platform is featured in 46 presentations at the 2026 CTAD conference, including 10 oral presentations. Researchers use NULISA to stratify patients, enhance brain-derived p-tau217 testing, and explore new biomarkers like eMTBR-tau and TDP-43. The technology enables sensitive protein detection, aiding early disease detection, monitoring, and therapeutic response evaluation. Presentations highlight its ...
11-16 11:00
11月10日,Alamar Biosciences(ALMR)收涨13.51%,报31.84美元,成交额2097.03万美元,市值22.12亿美元。 行情数据...
11-10 06:24
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
GSK shares are trading higher. The company announced a strategic scientific collaboration with Alamar Biosciences where it will use the NULISA platform in a large-scale study,
11-04 20:54
Alamar Biosciences (NASDAQ:ALMR) raises FY2026 sales outlook from $116.000 million-$120.000 million to $121.000 million-$123.000 million vs $118.632 million estimate.
11-04 05:13
11月3日,Alamar Biosciences(ALMR)收跌5.42%,报28.94美元,成交额2567.89万美元,市值20.08亿美元。 行情数据 •...
11-03 06:25
A study published in *Nature Communications* identified a 10-protein blood signature for amyotrophic lateral sclerosis (ALS) with 98.3% balanced accuracy, outperforming existing biomarkers like neurofilament light chain (NFL). The signature combines established markers like NFL and phosphorylated tau with six novel proteins, improving diagnostic accuracy and reducing false positives. This research, conducted by Emory University using Alamar Biosc...
10-28 20:05
10月27日,Alamar Biosciences(ALMR)收跌0.98%,报30.39美元,成交额1933.98万美元,市值21.09亿美元。 行情数据 ...
10-27 05:25
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:31